mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.064 |
0.2 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.2 |